HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: HER-2 pulsed Dendritic Cell Vaccine
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Abramson Cancer Center at Penn Medicine